CWM
MXCT icon

Cabot Wealth Management’s MaxCyte MXCT Stock Holding History

Cabot Wealth Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.3K Hold
88,623
– – 0.01% 139
2025
Q4 		$137K Buy
+88,623
New +$142K 0.02% 138

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Cabot Wealth Management's MXCT Position: Q1 2026 in Review

Cabot Wealth Management held its MaxCyte (MXCT) position steady in Q1 2026 at 88,623 shares worth $62.3K. The position accounts for 0.01% of the portfolio, ranked #139.

Cabot Wealth Management first reported a position in MXCT in Q4 2025 and has held it in 2 quarters since. The position peaked at $137K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Cabot Wealth Management held 88,623 shares of MaxCyte worth $62.3K as of Q1 2026.
  • Cabot Wealth Management left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up 0.01% of Cabot Wealth Management's portfolio in Q1 2026, its #139 holding.
  • Cabot Wealth Management first reported a position in MaxCyte in Q4 2025 and has held it in 2 quarters since.
  • Cabot Wealth Management's MaxCyte position peaked at $137K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Cabot Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.